Korean J Hematol 2004; 39(2):

Published online June 30, 2004

© The Korean Society of Hematology

철결핍성빈혈 치료 후 미성숙그물적혈구비율의 변화

유영진, 김성록, 한태희

인제대학교 의과대학 내과학교실,
인제대학교 의과대학 진단검사의과학교실

Immature Reticulocyte Fraction after Iron Therapy for Iron Deficiency Anemia

Young Jin Yuh, Sung Rok Kim, Tae Hee Han

Departments of Internal Medicine, Laboratory Medicine, Inje University College of Medicine, Seoul, Korea

Abstract

BACKGROUND:
Automated counting of reticulocyte introduced new reticulocyte parameters such as immature reticulocyte fraction (IRF). IRF is thought to be more sensitive than absolute or corrected reticulocyte count for detecting recovery of bone marrow function. The aim of this study is to assess the role of IRF for predicting the response of therapy after treatment of iron deficiency anemia.
METHODS : Patients with previously untreated iron deficiency anemia (blood hemoglobin <10.0 g/dL and serum ferritin <10ng/mL) were enrolled into this study. On the 8th day of iron therapy, Complete blood count (CBC) with reticulocyte count and IRF was assessed by RAM-1 reticulocyte autoanalyzer (Sysmex. Tokyo, Japan). IRF was defined as sum of the reticulocyte fraction of high-fluorescence intensity regions plus the fraction of middle fluorescence intensity regions. After 1 month of iron therapy, CBC was reassessed to evaluate the response of iron therapy. The correlation of the 8th day IRF and the change of hemoglobin level after 4 weeks of therapy was evaluated. The 8th day corrected reticulcyte count was also evaluated.
RESULTS:
From Jan. 2001 to May 2003, 27 patients with iron deficiency anemia (3 men and 24 women) entered into this study. We evaluated 21 patients, excluding 6 patients who were lost to follow-up or refused blood sampling after 1 month of iron therapy. The range of pretreatment hemoglobin level was 3.3-9.7g/dL (median 7.5g/dL). The 8th day IRF was 0.06- 0.39 (median 0.15). Ten patients had the low IRF (IRF ≤ 0.15). Four of them (40%) had their hemoglobin level increased by more than 3g/dL. On the other side, 11 patients had high IRF (IRF >0.15) and 10 of them (91%) had their hemoglobin level increased by more than 3g/dL. This difference was significant (P=0.024). However, the 8th day IRF was not correlated with the change of hemoglobin as strongly as the 8th day corrected reticulocyte count (Pearson coefficient 0.420 vs 0.693).
CONCLUSION:
For the patients with iron deficiency anemia, the 8th day of treatment IRF correlates with the response of iron treatment, but the 8th day of treatment corrected reticulocyte count has a stronger correlation. (Korean J Hematol 2004;39:103~108)

Keywords Iron deficiency anemia, Reticulocyte, Immature reticulocyte fraction

Article

Korean J Hematol 2004; 39(2): 103-108

Published online June 30, 2004

Copyright © The Korean Society of Hematology.

철결핍성빈혈 치료 후 미성숙그물적혈구비율의 변화

유영진, 김성록, 한태희

인제대학교 의과대학 내과학교실,
인제대학교 의과대학 진단검사의과학교실

Immature Reticulocyte Fraction after Iron Therapy for Iron Deficiency Anemia

Young Jin Yuh, Sung Rok Kim, Tae Hee Han

Departments of Internal Medicine, Laboratory Medicine, Inje University College of Medicine, Seoul, Korea

Abstract

BACKGROUND:
Automated counting of reticulocyte introduced new reticulocyte parameters such as immature reticulocyte fraction (IRF). IRF is thought to be more sensitive than absolute or corrected reticulocyte count for detecting recovery of bone marrow function. The aim of this study is to assess the role of IRF for predicting the response of therapy after treatment of iron deficiency anemia.
METHODS : Patients with previously untreated iron deficiency anemia (blood hemoglobin <10.0 g/dL and serum ferritin <10ng/mL) were enrolled into this study. On the 8th day of iron therapy, Complete blood count (CBC) with reticulocyte count and IRF was assessed by RAM-1 reticulocyte autoanalyzer (Sysmex. Tokyo, Japan). IRF was defined as sum of the reticulocyte fraction of high-fluorescence intensity regions plus the fraction of middle fluorescence intensity regions. After 1 month of iron therapy, CBC was reassessed to evaluate the response of iron therapy. The correlation of the 8th day IRF and the change of hemoglobin level after 4 weeks of therapy was evaluated. The 8th day corrected reticulcyte count was also evaluated.
RESULTS:
From Jan. 2001 to May 2003, 27 patients with iron deficiency anemia (3 men and 24 women) entered into this study. We evaluated 21 patients, excluding 6 patients who were lost to follow-up or refused blood sampling after 1 month of iron therapy. The range of pretreatment hemoglobin level was 3.3-9.7g/dL (median 7.5g/dL). The 8th day IRF was 0.06- 0.39 (median 0.15). Ten patients had the low IRF (IRF ≤ 0.15). Four of them (40%) had their hemoglobin level increased by more than 3g/dL. On the other side, 11 patients had high IRF (IRF >0.15) and 10 of them (91%) had their hemoglobin level increased by more than 3g/dL. This difference was significant (P=0.024). However, the 8th day IRF was not correlated with the change of hemoglobin as strongly as the 8th day corrected reticulocyte count (Pearson coefficient 0.420 vs 0.693).
CONCLUSION:
For the patients with iron deficiency anemia, the 8th day of treatment IRF correlates with the response of iron treatment, but the 8th day of treatment corrected reticulocyte count has a stronger correlation. (Korean J Hematol 2004;39:103~108)

Keywords: Iron deficiency anemia, Reticulocyte, Immature reticulocyte fraction

Blood Res
Volume 59 2024

Stats or Metrics

Share this article on

  • line

Related articles in BR

Blood Research

pISSN 2287-979X
eISSN 2288-0011
qr-code Download